Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
By V. Corman, O. Landt, M. Kaiser, R. Molenkamp, A. Meijer, D. Chu, T. Bleicker, Sebastian Brünink, J. Schneider, Marie L Schmidt and 14 more. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2020
6,734 citations recorded by the source corpus.
Background The ongoing outbreak of the recently emerged novel coronavirus (2019-nCoV) poses a challenge for public health laboratories as virus isolates are unavailable while there is growing evidence that the outbreak is more widespread than initially thought, and international spread through travellers does already occur. Aim We aimed to develop and deploy robust diagnostic methodology for use in public health laboratory settings without having virus material available. Methods Here we present a validated diagnostic workflow for 2019-nCoV, its design relying on close genetic relatedness of 2019-nCoV with SARS coronavirus, making use of synthetic nucleic acid technology. Results The workflow reliably detects 2019-nCoV, and further discriminates 2019-nCoV from SARS-CoV. Through coordination between academic and public laboratories, we confirmed assay exclusivity based on 297 original clinical specimens containing a full spectrum of human respiratory viruses. Control material is made available through European Virus Archive – Global (EVAg), a European Union infrastructure project. Conclusion The present study demonstrates the enormous response capacity achieved through coordination of academic and public laboratories in national and European research networks.
Subfields: Infectious Diseases
View Paper: https://www.semanticscholar.org/paper/6540e69c46de411b58f80c89614a620d2be9dc29
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
- Kwok-Yung Yuen
- J. Chan
- K. To
- Yi-Wei Tang
- V. Cheng
- Kwok-Hung Chan
- A. Aschenbrenner
- Joachim L. Schultze
Citations in the corpus
- The epidemiology, diagnosis and treatment of COVID-19 (2020, neutral): “The E gene PCR was sufficient to diagnose a SARS-CoV-2 infection but the RdRp protocol was recommended to confirm a positive result [22 , 23] .”
- Coronavirus disease 2019: What we know? (2020, methodology): “Several specific and sensitive assays targeting RdRP, N, and E genes of the SARS‐CoV‐2 genome were designed to detect viral RNA in clinical specimens.(44) Lower respiratory tract samples provide the higher viral loads.”
- Laboratory diagnosis of emerging human coronavirus infections – the state of the art (2020, neutral): “SARS-CoV-2 specific RT-PCR that targets RdRp [59, 60] .”
- The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control (2020, methodology): “Three real-time RT-PCR techniques have been designed based on the E, RdRp, and N genes [89].”
- Amplification-free detection of SARS-CoV-2 with CRISPR-Cas13a and mobile phone microscopy (2020, positive): “testing patient samples, we examined an additional set of crRNAs (crRNAs 19–22) (Table S1) targeting the viral E gene, based on published qPCR primer and Cas12 guide sets (Broughton et al., 2020; Corman et al., 2020) (Figure S2A).”
- Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients. (2020, neutral): “A number of cases with false-negative RT-PCR results were reported in the early stages of the disease, possibly because of inadequate viral material in the sample or technical issues during nucleic acid extraction [8, 30].”
- CoroNet: A deep neural network for detection and diagnosis of COVID-19 from chest x-ray images (2020, neutral): “ients, such that positive patients can be isolated and treated. Currently, the main screening method used for detecting COVID-19 is real-time reverse transcription polymerase chain reaction (rRT-PCR) [4,5]. The test is done on respiratory samples of the patient and the results can be available withi”
- Covid-19 in Critically Ill Patients in the Seattle Region — Case Series (2020, background): “Half the patients (12) died between ICU day 1 and day 18, including 4 patients who had a do-not-resuscitate order on admission.”
- The SARS-CoV-2 outbreak: What we know (2020, methodology): “The full gene sequence of SARS-CoV-2 has now been obtained and samples can be collected from the upper respiratory tract (oropharyngeal and nasopharyngeal) and lower respiratory tract (endotracheal aspirate, expectorated sputum, or bronchoalveolar lavage) of patients suspected SARS-CoV-2 infection f”
- SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup (2020, neutral): “Nucleic acid−based tests for detection of the virus during acute disease are in use worldwide (Chu et al., 2020; Corman et al., 2020).”